Therapeutic trends of priming mesenchymal stem cells: A bibliometric analysis
Mesenchymal stem cells (MSCs) have gained substantial attention in regenerative medicine due to their multilineage differentiation potential and immunomodulatory capabilities. MSCs have demonstrated therapeutic promise in numerous preclinical and clinical studies across a variety of diseases, includ...
Prif Awduron: | Kamal Hezam, Enze Fu, Jun Zhang, Zongjin Li |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
Elsevier
2024-07-01
|
Cyfres: | Biochemistry and Biophysics Reports |
Pynciau: | |
Mynediad Ar-lein: | http://www.sciencedirect.com/science/article/pii/S2405580824000724 |
Eitemau Tebyg
-
Safety assessment of equine allogeneic tenogenic primed mesenchymal stem cells in horses with naturally occurring tendon and ligament injuries
gan: Stephanie Carlier, et al.
Cyhoeddwyd: (2024-02-01) -
Superior protective effects of PGE2 priming mesenchymal stem cells against LPS-induced acute lung injury (ALI) through macrophage immunomodulation
gan: Kamal Hezam, et al.
Cyhoeddwyd: (2023-03-01) -
Nisin-preconditioned mesenchymal stem cells combatting nosocomial Pseudomonas infections
gan: Sara Enayati, et al.
Cyhoeddwyd: (2024-06-01) -
Improving the therapeutic profile of MSCs: Cytokine priming reduces donor-dependent heterogeneity and enhances their immunomodulatory capacity
gan: Jaris Valencia, et al.
Cyhoeddwyd: (2025-02-01) -
Improved therapeutics of modified mesenchymal stem cells: an update
gan: Dickson Kofi Wiredu Ocansey, et al.
Cyhoeddwyd: (2020-01-01)